MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Kodu・Aktsiate loetelu・VolitionRX Ltd

VolitionRX Ltd

Suletud

0.35 29.63

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.27

Max

0.37

Põhinäitajad
By Trading Economics
Sissetulek	936K -5.4M
Müük	221K 627K
Kasumimarginaal	-857.414
Töötajad	75
EBITDA	1.3M -4.2M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+703.57% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-12M 34M
Eelmine avamishind	-29.28
Eelmine sulgemishind	0.35

VolitionRX Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. jaan 2026, 23:08 UTC

Omandamised, ülevõtmised, äriostud

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8. jaan 2026, 21:39 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8. jaan 2026, 20:54 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Restart Merger Talks -- Update

8. jaan 2026, 20:44 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Restart Merger Talks

8. jaan 2026, 17:05 UTC

Omandamised, ülevõtmised, äriostud

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8. jaan 2026, 16:43 UTC

Suurimad hinnamuutused turgudel

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8. jaan 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. jaan 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8. jaan 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. jaan 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8. jaan 2026, 22:30 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8. jaan 2026, 21:53 UTC

Tulu

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. jaan 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. jaan 2026, 21:10 UTC

Omandamised, ülevõtmised, äriostud

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8. jaan 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8. jaan 2026, 21:09 UTC

Omandamised, ülevõtmised, äriostud

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8. jaan 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8. jaan 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8. jaan 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

8. jaan 2026, 17:48 UTC

Tulu

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. jaan 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. jaan 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. jaan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

8. jaan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. jaan 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8. jaan 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

8. jaan 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8. jaan 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8. jaan 2026, 15:23 UTC

Omandamised, ülevõtmised, äriostud

Paramount Defends Its Hostile Bid for Warner -- Update

Võrdlus sarnastega

Hinnamuutus

VolitionRX Ltd Prognoos

Hinnasiht

By TipRanks

703.57% tõus

12 kuu keskmine prognoos

Keskmine 2.25 USD 703.57%

Kõrge 3 USD

Madal 1.5 USD

Põhineb 3 Wall Streeti analüütiku instrumendi VolitionRX Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi VolitionRX Ltd aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.